This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paul, R.
Right arrow Articles by Schäfer, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paul, R.
Right arrow Articles by Schäfer, K. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2001, p. 962-965, Vol. 45, No. 3
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.3.962-965.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Mutations of the Helicobacter pylori Genes rdxA and pbp1 Cause Resistance against Metronidazole and Amoxicillin

Ralf Paul,*,1 Stefan Postius,2 Klaus Melchers,2 and Klaus P. Schäfer2

Yale University, New Haven, Connecticut 06511,1 and Byk Gulden Pharmaceuticals, Konstanz, Germany2

Received 9 June 2000/Returned for modification 17 August 2000/Accepted 25 November 2000


    ABSTRACT
Top
Abstract
Text
References

To investigate amoxicillin and metronidazole resistance of Helicobacter pylori, we compared putative resistance genes between resistant strains obtained in vitro and their sensitive parent strain. All metronidazole-resistant strains had rdxA mutations, and an amoxicillin-resistant strain had pbp1 and pbp2 mutations. By transforming PCR products of these mutated genes into antibiotic-sensitive strains, we showed that rdxA null mutations were sufficient for metronidazole resistance, while pbp1 mutations contributed to amoxicillin resistance of H. pylori.


    TEXT
Top
Abstract
Text
References

Although most infections with Helicobacter pylori are asymptomatic, and some might even be beneficial for the host, the pathogen is usually eradicated with antibiotics such as amoxicillin and metronidazole in order to cure gastritis and peptic ulcer diseases (3, 4). Resistance against metronidazole is common among H. pylori strains, while there are only a few reports of amoxicillin-resistant H. pylori strains (6, 8; M. Guslandi, Letter, Lancet 353:241-242, 1999; A. A. van Zwet, C. M. Vandenbroucke-Grauls, J. C. E. Thijs, J. van der Wouden, M. M. Gerrits, J. G. Kusters, and C. M. Vandenbrouke-Grauls, Letter, Lancet 352:1595, 1998).

Metronidazole resistance of H. pylori was shown to be due to the mutational inactivation of rdxA (7, 11). In turn, a metronidazole-resistant strain (Mtzr) was rendered sensitive when complemented with the rdxA gene of a metronidazole-sensitive strain (Mtzs). It was concluded that RdxA functions as a metronidazole-reducing nitroreductase (11). Resistance against beta -lactam antibiotics like amoxicillin is generally due to hydrolysis by a beta -lactamase (5) or by mutational modification of the penicillin binding proteins (13).

To investigate the molecular basis for antibiotic resistance in H. pylori, we did an in vitro selection for amoxicillin and metronidazole resistance on the strains 503 (ATCC 43503) and 69A (69A and 888-0: clinical isolates obtained from R. Haas, Max-von Pettenkofer-Institut, Munich, Germany). In contrast to other investigators (12, 15), we performed the selection not on agar plates, but in liquid culture (brain heart infusion medium [BHI; Difco-BD Biosciences, Md.] plus 5% fetal calf serum [FCS; Eurobio, Les Ulis, France]) at 37°C with microaerobic incubation (5 to 6% O2, 8 to 10% CO2) in the presence of these antibiotics. The MIC was determined by inoculating logarithmically growing H. pylori cells with an optical density at 578 nm (OD578) of 0.04 in 10 ml of BHI-5% FCS in 50-ml cell culture flasks (Greiner) on a shaker incubator at 90 rpm. The MIC of metronidazole was defined as no OD578 increase in 10 to 14 days, and that of amoxicillin was defined as growth to an OD578 lower than 0.4, with no increase after the first 24 h of incubation. We obtained stable metronidazole resistance after three serial passages over the course of 8 to 10 days with increasing metronidazole concentration in the growth medium (from 2 µg/ml to 25 µg/ml). The metronidazole MIC for nine independently selected 69A/Mtzr and 503/Mtzr strains was >25 µg/ml, while that for strains 503 and 69A was <5 µg/ml (data not shown). These results correspond to the observation of metronidazole resistance developing de novo during the course of a typical antibiotic therapy (1). In vitro selection of amoxicillin-resistant H. pylori strains was done similarly. Since the amoxicillin MIC for strains 503 and 69A was 0.02 to 0.05 µg/ml, we began selection at an amoxicillin concentration of 0.01 µg/ml. After 11 passages and 35 days under the permanent selective pressure of amoxicillin, the amoxicillin MIC for strain 69A reached 0.5 to 1 µg/ml, and after 35 passages and 89 days, an amoxicillin MIC of 15 µg/ml for the highly resistant strain 69A/Amxr was obtained. Comparable selection results were obtained for the strain 503 (data not shown). In contrast to other Amxr strains described in the literature (9), the resistance was stable after cultivation in the absence of antibiotics and storage at -80°C. The induction of resistance was specific for the antibiotic used for selection. Amoxicillin-resistant strains remained sensitive to metronidazole and vice versa.

To investigate the molecular mechanisms for resistance, we sequenced putative resistance genes from 69A strains: five independently selected 69A/Mtzr strains and one 69A/Amxr strain. The rdxA gene of each 69A/Mtzr strain had at least one mutation compared to the copy of the wild-type 69A strain (Fig. 1A). In three cases, the mutations caused stop codons in the rdxA open reading frame, which is also common for metronidazole-resistant clinical isolates (Fig. 1B). In the remaining two strains, the mutations caused either one or two amino acid changes at positions conserved in metronidazole-sensitive strains (Fig. 1B). The 69A/Amxr strain had no rdxA mutation (Fig. 1A), but had four pbp1 mutations (S414R, Y484C, T541I, and P600T) and one pbp2 mutation (T498I). All of these mutations cause amino acid changes at positions conserved in the Amxs strains 26695 (16), J99 (2), and 69A (GenBank accession no. AF315503 and AF315504) and were located in the putative transpeptidase domains of the proteins (10).


View larger version (76K):
[in this window]
[in a new window]
 
FIG. 1.   Alignment of RdxA proteins from H. pylori 69A strains selected for antibiotic resistance (A) and those of H. pylori wild-type strains (B). (A) The strains 69A and 69A/Amxr were metronidazole sensitive, and the 69A/Mtzr1 to -5 strains were metronidazole resistant. (B) H. pylori strains 26695, 503, 69A, and 500 were metronidazole sensitive, and H. pylori strains 439 and 504 (ATCC 43504) were metronidazole resistant. A black background shows the conservation of amino acid residues. H. pylori amino acid sequences are given as follows: 26695, reference 16; strains 500 and 439, reference 11; strain 503, GenBank accession no. AF316109; strain 504, accession no. AF315501; and strain 69A, accession no. AF315502.

To prove that these mutations were indeed responsible for antibiotic resistance, we amplified these genes by PCR, purified the DNA by gel electrophoresis, and transformed it into antibiotic-sensitive strains. To do this, we used a simplified protocol for transformation of H. pylori, in which we added linear PCR fragments without an additional resistance marker to logarithmically growing H. pylori and then selected for transformants with amoxicillin or metronidazole, respectively. After transformation with the mutated rdxA genes from four 69A/Mtzr strains, bacteria of three metronidazole-sensitive H. pylori strains (26695, 69A, and 888-0) were rendered resistant (Table 1). Transformation with the mutated pbp1 gene from the 69A/Amxr strain rendered bacteria of these strains (26695, 69A, and 888-0) moderately amoxicillin resistant (MIC of 0.5 to 1 µg/ml). Transformation with the pbp2 gene from 69A/Amxr caused no amoxicillin resistance. The cotransformation of pbp1 and pbp2 did not show increased resistance compared to transformation with pbp1 alone (Table 1).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Transformation of mutated genes into antibiotic-sensitive H. pylori with metronidazole or amoxicillin selection mediuma

To exclude the possibility that antibiotic resistance after transformation was due to a different spontaneous mutation, we sequenced the rdxA genes from six transformed metronidazole-resistant strains and the pbp1 genes from two transformed amoxicillin-resistant strains. In all but one case, we found the same mutations as in the respective donor strain (Table 2). The only exception was observed for transformation with the rdxA gene of 69A/Mtzr4: The rdxA gene from 69A/Mtzr4 contained two mutations (C19Y and C184F), while H. pylori transformed with this gene acquired only the C19Y mutation (Table 2). We therefore do not know if the C184F mutation is involved in metronidazole resistance.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Sequences of rdxA and pbp1 genes from antibiotic-resistant H. pylori strains gained by transformation with mutated rdxA and pbp1 genes

Our findings independently confirm previous results (7, 11, 14) and expand their data in the sense that not only stop codons and extensive deletions in the rdxA open reading frame cause metronidazole resistance, but so do single amino acid changes. We have proven that two alterations of the RdxA protein, C19Y and T49K, have the same effect on the phenotype of H. pylori (Mtzsright-arrowMtzr) as rdxA null mutations and conclude that they severely affect RdxA function. The same is true for deletion of the C-terminal 14 amino acids of RdxA. By systematically transforming rdxA genes with single mutations into metronidazole-sensitive H. pylori strains by the simplified protocol, we have illustrated how it would be possible to identify additional residues essential for RdxA function. We have also shown that pbp1 mutations can affect amoxicillin resistance, but are not sufficient for the high-level amoxicillin resistance of 69A/Amxr. This indicates that mutations in more than one gene are probably required to render H. pylori amoxicillin resistant. This could explain the many cycles necessary for the in vitro selection of amoxicillin-resistant H. pylori strains and their low occurrence in vivo.


    ACKNOWLEDGMENTS

The work described here was supported by a grant from the German Ministry of Education and Research (BMBF; BEO/22 031 0777).

We thank Klaus Bensch and Wolfram Steinhilber for discussions.


    FOOTNOTES

* Corresponding author. Mailing address: Yale University, 266 Whitney Ave., New Haven, CT 06511. Phone: (203) 432-3506. Fax: (203) 432-5713. E-mail: Ralf.Paul{at}Yale.edu.


    REFERENCES
Top
Abstract
Text
References

1. Adamek, R. J., S. Suerbaum, B. Pfaffenbach, and W. Opferkuch. 1998. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin---influence on treatment outcome. Am. J. Gastroenterol. 93:386-389[Medline].
2. Alm, R. A., L. S. Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, et al. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176-180[CrossRef][Medline].
3. Blaser, M. J. 1997. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 349:1020-1022[CrossRef][Medline].
4. Blaser, M. J. 1998. Helicobacter pylori and gastric diseases. Br. Med. J. 316:1507-1510[Free Full Text].
5. Davies, J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science 264:375-382[Abstract/Free Full Text].
6. Debets-Ossenkopp, Y. J., A. J. Herscheid, R. G. Pot, E. J. Kuipers, J. G. Kusters, and C. M. Vandenbroucke-Grauls. 1999. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and trovafloxacin in The Netherlands. J. Antimicrob. Chemother. 43:511-515[Abstract/Free Full Text].
7. Debets-Ossenkopp, Y. J., R. G. J. Pot, D. J. van Westerloo, A. Goodwin, C. M. J. E. Vandenbroucke-Grauls, D. E. Berg, P. S. Hoffman, and J. G. Kusters. 1999. Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637. Antimicrob. Agents Chemother. 43:2657-2662[Abstract/Free Full Text].
8. Dore, P. M., A. Piana, M. Carta, A. Atzei, B. M. Are, I. Mura, et al. 1998. Amoxicillin resistance is one reason for failure of amoxicillin-omeprazole treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 12:635-639[CrossRef][Medline].
9. Dore, P. M., D. Y. Graham, and A. R. Sepulveda. 1999. Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori. Helicobacter 4:154-161[CrossRef][Medline].
10. Goffin, C., and J. M. Ghuysen. 1998. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62:1079-1093[Abstract/Free Full Text].
11. Goodwin, A., D. Kersulyte, G. Sisson, S. J. Veldhuyzen van Zanten, D. E. Berg, and P. S. Hoffman. 1998. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol. Microbiol. 28:383-393[CrossRef][Medline].
12. Sörberg, M., H. Hanberger, M. Nilsson, A. Björkman, and L. E. Nilsson. 1998. Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. Antimicrob. Agents Chemother. 42:1222-1228[Abstract/Free Full Text].
13. Spratt, B. G. 1994. Resistance to antibiotics mediated by target alterations. Science 264:388-393[Abstract/Free Full Text].
14. Tankovic, J., D. Lamarque, J.-C. Delchier, C.-J. Soussy, A. Labigne, and P. J. Jenks. 2000. Frequent association between alteration of the rdxA gene and metronidazole resistance in French and North African isolates of Helicobacter pylori. Antimicrob. Agents Chemother. 44:608-613[Abstract/Free Full Text].
15. Tenney, J. H., R. W. Maack, and G. R. Chippendale. 1983. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar. Antimicrob. Agents Chemother. 23:188-189[Abstract/Free Full Text].
16. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547[CrossRef][Medline].


Antimicrobial Agents and Chemotherapy, March 2001, p. 962-965, Vol. 45, No. 3
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.3.962-965.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Co, E.-M. A., Schiller, N. L. (2006). Resistance Mechanisms in an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori. Antimicrob. Agents Chemother. 50: 4174-4176 [Abstract] [Full Text]  
  • Megraud, F (2004). H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53: 1374-1384 [Full Text]  
  • Kwon, D. H., Dore, M. P., Kim, J. J., Kato, M., Lee, M., Wu, J. Y., Graham, D. Y. (2003). High-Level {beta}-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 47: 2169-2178 [Abstract] [Full Text]  
  • Okamoto, T., Yoshiyama, H., Nakazawa, T., Park, I.-D., Chang, M.-W., Yanai, H., Okita, K., Shirai, M. (2002). A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J Antimicrob Chemother 50: 849-856 [Abstract] [Full Text]  
  • Gerrits, M. M., Schuijffel, D., van Zwet, A. A., Kuipers, E. J., Vandenbroucke-Grauls, C. M. J. E., Kusters, J. G. (2002). Alterations in Penicillin-Binding Protein 1A Confer Resistance to {beta}-Lactam Antibiotics in Helicobacter pylori. Antimicrob. Agents Chemother. 46: 2229-2233 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paul, R.
Right arrow Articles by Schäfer, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paul, R.
Right arrow Articles by Schäfer, K. P.